Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
PLUR Pluri Inc
- Stocks
- Healthcare
- NASDAQ: PLUR
Price (delayed)
$5.21
Market cap
$40.81M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.62
Enterprise value
$31.9M
Pluristem Therapeutics Inc. is a leading regenerative medicine company developing novel placenta-based cell therapy product candidates. The Company has reported robust clinical trial data in multiple indications for its patented
Highlights
PLUR's debt has dropped by 100% since the previous quarter and by 100% year-on-year
The gross profit has soared by 62% YoY and by 14% from the previous quarter
The net income has declined by 4.3% since the previous quarter but it is up by 4.2% year-on-year
The gross margin has contracted by 47% YoY and by 25% from the previous quarter
Key stats
What are the main financial stats of PLUR
Market
Valuations
Earnings
Shares outstanding
7.83M
Market cap
$40.81M
Enterprise value
$31.9M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
33.07
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
30.85
Revenue
$1.03M
Gross profit
$539,000
Operating income
-$21.59M
Net income
-$20.71M
EBIT
-$21.54M
EBITDA
-$21.27M
Free cash flow
-$18.22M
Per share
Balance sheet
Liquidity
EPS
-$3.62
EPS diluted
-$3.62
Free cash flow per share
-$2.78
Book value per share
N/A
Revenue per share
$0.16
TBVPS
$5.7
Total assets
$37.41M
Total liabilities
N/A
Debt
$0
Equity
N/A
Working capital
N/A
Debt to equity
N/A
Current ratio
N/A
Quick ratio
N/A
Net debt/EBITDA
0.42
Margins
Efficiency
Dividend
EBITDA margin
-2,057.1%
Gross margin
52.1%
Net margin
-2,003.3%
Operating margin
-2,087.9%
Return on assets
-57.8%
Return on equity
N/A
Return on invested capital
-52.9%
Return on capital employed
N/A
Return on sales
-2,082.8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
PLUR stock price
How has the Pluri stock price performed over time
Intraday
3.37%
1 week
-9.39%
1 month
43.92%
1 year
-16.91%
YTD
21.87%
QTD
21.16%
Financial performance
How have Pluri's revenue and profit performed over time
Revenue
$1.03M
Gross profit
$539,000
Operating income
-$21.59M
Net income
-$20.71M
Gross margin
52.1%
Net margin
-2,003.3%
Pluri's operating margin has surged by 69% YoY and by 35% QoQ
PLUR's net margin has surged by 68% year-on-year and by 32% since the previous quarter
The gross profit has soared by 62% YoY and by 14% from the previous quarter
Pluri's revenue has soared by 53% from the previous quarter
Price vs fundamentals
How does PLUR's price correlate with its fundamentals
Growth
What is Pluri's growth rate over time
Valuation
What is Pluri stock price valuation
P/E
N/A
P/B
N/A
P/S
33.07
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
30.85
Pluri's EPS has increased by 12% YoY
Pluri's revenue has soared by 53% from the previous quarter
PLUR's P/S is 39% below its last 4 quarters average of 52.6
Efficiency
How efficient is Pluri business performance
PLUR's return on invested capital has dropped by 65% year-on-year and by 21% since the previous quarter
Pluri's return on sales has surged by 64% YoY and by 32% QoQ
Pluri's return on assets has decreased by 16% YoY and by 3.4% QoQ
Dividends
What is PLUR's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for PLUR.
Financial health
How did Pluri financials performed over time
The company's total assets rose by 21% QoQ and by 2.8% YoY
PLUR's debt has dropped by 100% since the previous quarter and by 100% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.